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http://www.diagnosticpathology.org/content/7/1/61CASE REPORT Open AccessInvasive salivary duct carcinoma ex pleomorphic
adenoma of the parotid gland: a teaching case
giving rise to the genuine diagnostic difficulty on
an inadequate cytology specimen
Sohsuke Yamada1,3*, Atsunori Nabeshima1, Takahisa Tabata2, Xin Guo1, Takashi Tasaki1, Ke-Yong Wang1,
Shohei Shimajiri1 and Yasuyuki Sasaguri1Abstract: A history of a recent rapid increase in long-standing swelling mass was presented in the right parotid
gland of an 85-year-old male. The inadequate cytologic specimens contained few small clusters of three-
dimensional malignant epithelial cells having hyperchromatic pleomorphic nuclei and prominent nucleoli, adjacent
to a cluster of benign monomorphic myoepithelial cells. We first interpreted it merely as an adenocarcinoma, not
otherwise specified. A radical parotidectomy was performed, and gross examination revealed an encapsulated and
firm tumor lesion, looking grayish-blue to yellowish-white, focally associated with extracapsular invasion. On
microscopic examination, the tumor was predominantly composed of a proliferation of highly atypical epithelial
cells having abundant eosinophilic cytoplasm, often arranged in a Roman-bridge appearance with foci of comedo
necrosis, alternating with extensive infiltration to adjacent stroma in a trabecular or alveolar fashion with severe
vessel permeation. Within the background of pleomorphic adenoma, the carcinoma cells sometimes replaced
ductal luminal cells while retaining an intact-like myoepithelial layer. Therefore, we finally made a diagnosis of
invasive salivary duct carcinoma ex pleomorphic adenoma. We should be aware that owing to its characteristic
features, cytopathologists might be able to determine correct diagnosis, based on multiple and adequate
samplings.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2126158270695815
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Among all salivary gland neoplasms, carcinoma ex pleo-
morphic adenoma (Ca ex PA) accounts for approximately
3.6% [1], whereas constitutes 6.2% of all PA and 11.6% of
all malignant salivary gland neoplasms [1,2]. Despite of
that, Ca ex PA is uncommon and has a prevalence rate
of 5.6 cases per 100,000 malignant neoplasms and a
yearly incidence rate of 0.17 tumors per 1 million people
[1,2]. This neoplasm is defined as an epithelial malignant* Correspondence: sousuke@med.uoeh-u.ac.jp
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reproduction in any medium, provided the ortransformation within a primary (de novo) or recurrent
PA, and often poses a diagnostic challenge to clinicians
and cytopathologists, since its entity is difficult to diagnose
pre-operatively [3,4]. In fact, Ca ex PA can be asymptomatic
as most of them are not widely invasive on gross find-
ings and often have similar clinical presentations as PA,
however, patients with Ca ex PA have a poor prognosis
due to infiltrative and destructive behavior, and thus,
early and accurate diagnosis and aggressive surgical
treatment (i.e., total or radical parotidectomy) can in-
crease their survival rates [1-5]. Although any form of
carcinoma can be observed and also be a mixture of
subtypes, the malignant component of Ca ex PA is most
often adenocarcinoma, not otherwise specified (NOS),
and sometimes, may be salivary duct carcinoma (SDC),l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mucoepidermoid carcinoma [1,2,4,6]. While, WHO states
that its component is most frequently a poorly differen-
tiated carcinoma, e.g., SDC or adenocarcinoma, NOS, or
an undifferentiated carcinoma [3].
On the other hand, SDC was first described by
Kleinsasser et al in 1968 [7], and to date, more than 100
cases have been reported and account for approximately
9% among all salivary gland neoplasms [8]. SDC is a dis-
tinctive but relatively common high grade adenocarcin-
oma arising from the excretory ductal epithelium of the
major salivary glands, especially the parotid gland [8-10].
Clinically, these tumors are characterized by aggressive
(i.e., infiltrative and destructive) behavior with local
recurrence, early and distant metastasis, invasion of
the facial nerve, and/or significant mortality [8-11].
Histopathologically, SDCs have a striking resemblance
to ductal carcinoma of the breast, exhibiting intraduc-
tal and infiltrating components [8,10,11]. In addition,
very intriguingly, they should show a broader clinico-
pathological spectrum and many cases of them may
develop within PA as a result of malignant transform-
ation of ductal epithelial cells [9,12]. It has been actually
reported that multifocal origin of SDC from major ex-
cretory ducts surrounding a PA was found [8]. By con-
trast, Simpson RHW et al. described that the majority
of them arise de novo (as in the breast) probably from a
pure in situ carcinoma [13]. Similar to Ca ex PA, aggres-
sive clinical management in the early stage of SDC
appears to be the only hope for good prognosis
[5,6,8-11]. Thus, it is critical to establish an accurate
preoperative diagnosis by fine-needle aspiration cy-
tology, however, previous studies have indicated the dif-
ficulty of correct characterization of Ca ex PA and/or
SDC due to sampling errors or inadequateness and mis-
interpretation [14,15].
In fact, invasive SDC ex PA could be relatively com-
mon disease, as compared with some recently published
case reports of very rare tumor cell types in the salivary
gland [16-18]. Despite of that, we report a case of SDC
ex PA, which originated from the parotid gland and par-
tially involved the surrounding soft tissue and lymph
nodes as a rapidly increased but long-standing swelling
mass. Based on the relatively inadequate cytology speci-
mens, we preoperatively interpreted it merely as an adeno-
carcinoma, NOS.
Materials and methods
The patient was an 85-year-old Japanese man. A fine-
needle aspiration from the parotid gland mass was per-
formed, followed by a radical parotidectomy. The tumor
specimens after fixation in 10% neutral buffered formalin
were embedded in paraffin for histological or immuno-
histochemical examinations. All immunohistochemicalstainings were carried out using Dako Envision kit (Dako
Cytomation Co., Glostrup, Denmark) according to the
manufacturer’s instructions. For transmission electron
microscopy (JEM-1200EX, JEOL Ltd., Tokyo, Japan), the
dehydrated tissue specimens, after fixed with 2.5% glu-
taraldehyde and immersed in 2% osmium tetroxide, were
embedded in epoxy resin.
Case presentation
The patient had a history of benign prostatic hyperplasia
2 years ago. There was no history of malignancy, im-
munosuppressive disorders, use of immunosuppressive
medications, or unusual infections.
He noticed a long-standing swelling mass in the right
parotid gland and an enlargement of the neck lymph
node 5 years before the resection. Following that, a recent
rapid increase of them was presented. Laboratory data, in-
cluding blood cell count, chemistry and tumor markers,
were within normal limits. A neck CT scan revealed a het-
erogeneously enhanced and poorly-demarcated mass,
measuring approximately 3 × 3 cm, in the right parotid
gland. CT scans of the chest and abdomen disclosed no
definite evidence of metastasis in the lymph nodes or
other organs. The patient was alive and well at 8 months
after the operation.
Pathological findings
The fine-needle aspiration cytology specimens were in-
adequate but consisted of few small clusters of cohesive
and three-dimensional pleomorphic tumor cells in a
papillary-like fashion without necrotic or hemorrhagic
backgrounds (Figure 1A), along with flat sheets of be-
nign monomorphic myoepithelial cells and a small
amount of metachromatic fibromyxoid stroma, repre-
sentative of benign PA (Figure 1A, inset). At the peri-
phery of these clusters and sheets, there were few,
scattered and tiny malignant tumor cells (Figure 1B).
The tumor cells showed large, polygonal, and round to
oval with moderate to marked pleomorphism and had
relatively abundant and finely granular cytoplasm
(Figure 1B). Additionally, the nuclei were hyperchro-
matic, medium to large in size, pleomorphic, and often
had prominent nucleoli (Figure 1B). Based on that, we
first interpreted it as an adenocarcinoma, NOS, and an
ordinary radical parotidectomy was performed.
On gross examination, the cut surface revealed an
encapsulated but poorly-demarcated, and predominantly
solid firm mass, measuring 32 × 25 × 12 mm, which
looked from grayish-blue to yellowish-white in colour,
almost corresponding to the areas from PA to SDC
(Figure 2A). This tumor lesion was superimposed with
central hemorrhage and foci of extracapsular invasion,
replacing one part of the parotid gland (Figure 2A). A




Figure 1 Cytomorphologic examination of the fine needle aspiration specimens. (A) The cytology specimens were inadequate, but
consisted of few small clusters of cohesive and three-dimensional pleomorphic tumor cells in a papillary-like fashion (rt. side), along with flat
sheets of benign monomorphic myoepithelial cells (lt. side) (Papanicolaou stains) and a small amount of metachromatic fibromyxoid stroma
(inset, Giemsa stains). Bar = 50 μm. (B) At the periphery of these clusters and sheets, there were scattered and tiny malignant tumor cells, having
relatively abundant and finely granular cytoplasm. Additionally, the nuclei were hyperchromatic, medium to large in size, pleomorphic, and often
had prominent nucleoli. Bar = 10 μm.
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was less than 50% in an acellular fashion, with transition
to the predominant SDC components in a cellular fashion,







Figure 2 Gross and microscopic examination, and schema of the rese
revealed an encapsulated but poorly-demarcated, and predominantly solid
yellowish-white in colour, almost corresponding to the areas from pleomo
salivary duct carcinoma (SDC) components, associated with central hemorr
(B) A scanning magnification of it showed that the PA components embed
to the predominant (more than 50%) SDC components (H&E stains). Bar = 1
yellow, and ED; red) was shown, likely displaying a sequential and stepwiseMicroscopic findings included the presence of well-
circumscribed so-called ‘intraductal (ID)’ and significantly
infiltrating so-called ‘extraductal (ED)’ components of the
SDC. The former ‘intraductal’ components showed aB
10mm
cted specimen. (A) On gross examination (inset), the cut surface
firm mass, measuring 32 × 25 mm, which looked from grayish-blue to
rphic adenoma (PA) to both ‘intraductal (ID)’ and ‘extraductal (ED)’
hage and foci of extracapsular invasion (lower, arrows). Bar = 10 mm.
ded in abundant chondroid matrix was less than 50%, with transition
0 mm. (C) The schema of these tumor components (PA; blue, ID;
progression.
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hyperchromatic pleomorphic nuclei and abundant eosino-
philic cytoplasm, often arranged in a Roman-bridge ap-
pearance with foci of comedo necrosis, typical of
mammary ductal carcinoma in situ (Figure 3A). Although
the PA components exhibited extensive chondromatous
or hyalinized change, the presence of residual benign duct-
ular structures in a two-cell pattern allowed their identifi-
cation, partly in which the carcinoma cells displayed a
minor ‘in situ’ component, characterized by malignant
transformation of ductal luminal cells with possible
preservation of the myoepithelial cell layer (Figure 3B).
Moreover, the luminal adenocarcinoma cells sometimes
revealed evidence of active “decapitation” secretion like
that seen in apocrine glands (Figure 3C). In contrast,
the latter ‘extraductal’ components demonstrated an ex-
tensive infiltration to the adjacent pre-existing PA
stroma and the extracapsular area, in a trabecular or al-
veolar fashion with severe vessel permeation and many
foci of lymph nodes metastases, also reminiscent of in-
vasive ductal carcinoma of the breast (Figure 3D). These




Figure 3 Microscopic examination of the invasive SDC ex PA. (A) In hi
highly atypical epithelial cells having hyperchromatic pleomorphic nuclei a
bridge appearance with foci of comedo necrosis (H&E stains, Original magn
the carcinoma cells occasionally displayed a minor ‘in situ’ component, cha
possible preservation of the myoepithelial cell layer (H&E stains, Original m
adenocarcinoma cells sometimes revealed evidence of active “decapitation
(D) In contrast, the ED components demonstrated an extensive infiltration
trabecular or alveolar fashion with severe vessel permeation (inset) (H&E stavery similar to breast carcinoma. The schema of these
tumor components (PA; blue, ID; yellow; and ED; red) is
summarized in Figure 2C.
Ultrastructural findings of the transition areas from
‘intraductal’ to ‘extraductal’ components showed that the
neoplastic columnar cells occasionally with luminal
microvilli had enlarged irregular nuclei with dispersed
chromatin and one or more prominent nucleoli, and
cytoplasm containing not only a large amount of orga-
nelles, such as endoplasmic reticulum, but secretory-like
granules (data not shown). The basally-located myoe-
pithelial cells were seen, and were neoplastic-like with
enlarged irregular nuclei and cytoplasmic dense bodies
of myofilaments, intermingled with collagen bands (data
not shown).
Immunohistochemically, these adenocarcinoma cells
were specifically positive for androgen receptor (AR; Bio-
Genex, San Ramon, CA, diluted 1:50) (Figure 4A) and
gross cystic disease fluid protein-15 (GCDFP-15; Signet
Laboratories, Inc., Dedham, MA, diluted 1:40) (Figure 4B)
in not only the ‘intraductal (ID)’ but the ‘extraductal (ED)’




gh power view, the ID components of SDC showed a proliferation of
nd abundant eosinophilic cytoplasm, often arranged in a Roman-
ification× 200). Bar = 100 μm. (B) Additionally, in the PA components,
racterized by malignant transformation of ductal luminal cells with
agnification× 200). Bar = 100 μm. (C) In the ID components, the luminal
” secretion (H&E stains, Original magnification× 400). Bar = 50 μm.
to the adjacent pre-existing PA stroma and the extracapsular area, in a
ins, Original magnification × 200). Bar = 100 μm.
Table 1 Immunohistochemical profile of the epithelial
components in the invasive SDC ex PA
Epithelial component
Antibodies PA ID ED
AR – + +
GCDFP15 – + +
CEA – + +
PSA – + +
HER2 0 3+ 3+
AE1/AE3 + + +
EMA + + +
ER – – –
PgR – – –
S100 – – –
p63 – – –
MIBI <1% 20% 60%
p53 <1% 20% 60%
PA: Pleomorphic adenoma, ID: “Intraductal” carcinoma, ED: “Extraductal”
carcinoma.
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California, USA, diluted 1:200, and Cam5.2; Becton
Dickinson Immunocytometry Systems, San Jose, CA,
diluted 1:1), EMA (Dako, diluted 1:100), carcinoembryo-
nic antigen (CEA; Dako, diluted 1:50), prostate specific
antigen (PSA; Dako, diluted 1:40), and HER2 protein
(Dako, diluted 1:1), but were negative for S-100 protein
(Dako, diluted 1:900), p63 (Dako, diluted, 1:30), estrogen
receptor (ER; Dako, 1:2), and progesterone receptor
(PgR; Dako, 1:6) (Table 1). In the case of the HER2
protein, the results were evaluated as 3+ (intermediate
to strong complete staining in > 10%) for membranous
immunohistochemical expression (Figure 4C), according
to the criteria of HercepTest (Dako). On the other
hand, Ki67 (MIB-1; Dako, diluted 1:50) labeling index
was approximately 20% or greater than 50% in the pro-
liferating atypical cells of the ‘intraductal’ or ‘extraductal’
components, respectively, whereas less than 1% in the
PA components (Table 1). Moreover, the positivity of
distinct nuclear staining for p53 (Dako, diluted 1:30)
was almost corresponding to the MIB-1 labeling index
in each components (Table 1). In contrast, the myoe-
pithelial cells of the PA and ‘intraductal’ components
are negative for AR (BioGenex) (Figure 4A), but positive
for S-100 protein (Dako) and p63 (Dako) (Figure 5A-B).








Figure 4 Immunohistochemical examination of the invasive SDC ex P
GCDFP-15 (B), and HER2 (C) in not only the ID (lt.) but ED (rt.) components
were negative for AR (A).neoplastic-like myoepithelial cells having mildly enlarged
and hyperchromatic nuclei were sometimes negative for
both of them (S-100 protein; Figure 5A, inset and p63;
Figure 5B, inset). Also, the lost of myoepithelial cells 
100µm GCDFP15 
ID ED B
A. (A, B, C). The carcinoma cells were strongly positive for AR (A),
. Conversely, the myoepithelial cells of the PA and ID components
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(Figure 5A-B).
Based on all these features, we suggested that these
proliferating carcinoma cells were characteristic of apo-
crine differentiation, and finally made a diagnosis of in-
vasive SDC ex PA of the parotid gland.
Discussion
Aggressive clinical treatment in the early stage for inva-
sive SDC is the only hope for better prognosis, due to a
high grade, malignant tumor, based on the infiltrative
and destructive behavior [8-11]. Thus, it is critical to es-
tablish an accurate preoperative diagnosis by fine-needle
aspiration cytology, the clinical utility of which in diag-
nosing salivary gland tumors has been generalized. The
cytologic findings of invasive SDC reflect the histopatho-
logical ones resembling invasive ductal carcinoma of the
breast, showing cohesive, three-dimensional clusters and
flat sheets of large and polygonal atypical cells having
abundant and finely granular cytoplasm, and prominent
nucleoli, arranged in an irregular branching, cribriform,
or papillary growth pattern as well as single cells forma-
tion in the background of frequent necrosis [15,19]. Add-
itionally, smears from Ca ex PA show moderate to high
cellularity with pleomorphic malignant cells in the back-
ground of biphasic components of PA, displaying sheets
of benign monomorphic epithelial cells along with meta-
chromatic, fibrillary and myxoid or chondroid stroma
[14]. As in the current case, although the specimens
were inadequate, the cytologic features were almost
similar to those as described above, even while neither
necrotic backgrounds nor any cribriform formations were
observed. Despite that, a confident and accurate diagnosis
of SDC ex PA was impossible on cytology, suggestively
due to sampling errors, lack of experience, cytomorpholo-
gic variety, and misinterpretation. Nevertheless, in casesA  
100µm S-100 protein 
Figure 5 Myoepithelial markers analysis of the invasive SDC ex PA in
S-100 protein (A) and p63 (B). By contrast, the myoepithelial cells of the PA
side) (Original magnification × 200, Bar = 100 μm). However, as to the ID co
mildly enlarged and hyperchromatic nuclei were sometimes negative for b
magnification × 400, Bar = 50 μm). Also, the lost of myoepithelial cells was fwith a strong clinical suspicion of Ca ex PA, such as ours,
multiple fine needle aspiration should be performed and
its suspicion should be raised to alert the pathologist, at
the very least.
An immunohistochemical analysis indicates that AR
and GCDFP-15 are highly and specifically expressed in
more than 80% and 90% of patients with SDC, respect-
ively, whereas ER and PgR, well known as common
breast carcinoma markers, are very weakly or negatively
stained [11,20-22]. Actually, one paper proposed that,
when the cytologic features of high grade adenocarcinoma
with a variety of cell morphology are difficult to make an
accurate diagnosis, immunostaining for AR and ER on
cytologic smears would be very useful for the diagnosis of
SDC [19].
On the other hand, the luminal SDC carcinoma cells
rarely show immunohistochemical expression of S-100
protein and p63, whereas the ‘reminiscent’ benign myoe-
pithelial cells reveal those strong expression in the ‘intra-
ductal’ and PA components [9-11,20-22], even while the
lost of myoepithelial cells is occasionally seen in the
transition areas from ‘intraductal’ to ‘extraductal’ compo-
nents [20], as in our case. Indeed, myoepithelial cells can
be considered as natural tumor suppressors, distinguish-
ing between early and advanced malignant tumors in the
transition from in situ to invasive carcinomas, and can
rarely undergo malignancy. However, in the present case,
the neoplastic-like enlarged myoepithelial cells in the
transition areas were sometimes negative for the above
myoepithelial markers. These features indicate that those
cells would not have apparent myoepithelial phenotypes,
but potentially neoplastic character, probably confirmed
by the ultrastructural findings. We could provide the
evidence for the first time that invasive SDC ex PA may
arise within or from PA as a result of neoplastic trans-
formation of outer supporting myoepithelial cells, as wellB  
100µm p63 
immunohistochemistry. (A, B) The carcinoma cells were negative for
and ID components were positive for S-100 protein and p63 (A-B, rt.
mponents, the neoplastic-like myoepithelial cells (arrowheads) having
oth of S-100 protein (A, inset) and p63 (B, inset) (Original
ocally apparent in the ID components (A-B, lt. side).
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studies will be further required to determine whether
our suggestion is significant after collecting and examining
a larger number of its cases.
Conclusion
We herein reported a case of an invasive SDC ex PA. The
present case was tentatively diagnosed as adenocarcinoma,
NOS on the examination of the cytology, because its
smears showed the inadequate and few components of
malignant cells. All cytopathologists should be aware that
its clinically and immunohistochemically characteristic
features, as well as multiple and adequate fine needle as-
piration, could lead to a correct diagnosis.
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